Evidence map›Paper›PMID 18312689›Full record

ArticleGenome biology2008

Gene expression-based screening for inhibitors of PDGFR signaling.

Alena A Antipova, Brent R Stockwell, Todd R Golub

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. High-throughput library screening identifies two novel NQO1 inducers in human lung cells.American journal of respiratory cell and molecular biology · 2012
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Alena A AntipovaCancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge Center, Cambridge, MA 02142, USA. alena.antipova@appliedbiosystems.com
Brent R Stockwell
Todd R Golub
Broad Institute · USColumbia University · US

Funding

Chemical Genetic Profiling of Engineered Tumor CellsR01CA097061 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI STOCKWELL, BRENT R. · 2002 to 2016
$4.8M
Howard Hughes Medical InstituteNCI NIH HHS CA97061
6 · The paper itself

Abstract

Here we describe a proof-of-concept experiment designed to explore the possibility of using gene expression-based high-throughput screening (GE-HTS) to find inhibitors of a signaling cascade, using platelet derived growth factor receptor (PDGFR) signaling as the example. The previously unrecognized ability of aurintricarboxylic acid to inhibit PDGFR signaling, discovered through a screen of 1,739 compounds, demonstrates the feasibility and generalizability of GE-HTS for the discovery of small molecule modulators of any signaling pathway of interest.

Indexed as

Aurintricarboxylic AcidCell Line, TumorDrug Evaluation, PreclinicalExtracellular Signal-Regulated MAP KinasesGene ExpressionHumansProtein Kinase InhibitorsReceptor, Platelet-Derived Growth Factor alphaReceptor, Platelet-Derived Growth Factor betaSignal TransductionStructure-Activity RelationshipAurintricarboxylic AcidExtracellular Signal-Regulated MAP KinasesProtein Kinase InhibitorsReceptor, Platelet-Derived Growth Factor alphaReceptor, Platelet-Derived Growth Factor beta

Identifiers

PMID18312689
PMCPMC2397499
OpenAlexW2149601257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.